Gujarat Themis Biosyn Limited has announced the opening of a special window for shareholders to re-lodge transfer requests and dematerialise physical shares, following regulatory guidelines issued by the Securities and Exchange Board of India (SEBI).

SEBI Circular Implementation

The company has implemented SEBI Circular No. HD/38/13/11(2)2026-MIRSDPOD/1/3750/2026 dated January 30, 2026, which mandates the opening of a special window for transfer and dematerialisation of physical securities. This facility will remain available for one year from February 05, 2026 to February 04, 2027.

Eligibility Criteria and Process

The special window is specifically designed for shareholders who had sold or purchased shares prior to April 01, 2019 and fall into specific categories. The company has provided a detailed eligibility matrix to clarify the applicability:

Only requests accompanied by original share certificates, transfer deeds, and supporting documents will be considered under this special window. Shares transferred through this process will be mandatorily credited to the transferee in dematerialised mode only.

Lock-in Period and Restrictions

Shares transferred under this special window will be subject to a lock-in period of one year from the date of registration of transfer. During this period, such shares cannot be transferred, sold, or pledged, ensuring compliance with regulatory requirements.

Public Notice and Communication

Gujarat Themis Biosyn Limited published newspaper notices in Western Times (English) and Western Times (Gujarati) editions on Wednesday, April 8, 2026, to inform shareholders about this opportunity. The company's letter to BSE Limited and National Stock Exchange of India Limited, referenced as GTBL/CS/BSE/NSE/2026-27/02, confirms the publication of these notices.

Contact Information for Shareholders

Shareholders wishing to avail of this special window can contact the company's Registrar & Transfer Agent, MUFG Intime India Private Limited (formerly Link Intime India Private Limited), located at C-101, Embassy 247, L.B.S. Marg Vikhroli (West), Mumbai-400083. The SEBI circular is also available on the company's website at www.gtbl.in/news/ for reference.

The company encourages all eligible investors to initiate necessary actions without delay to regularise their pending transfer cases during this one-year window period.

Gujarat Themis Biosyn Limited has submitted its quarterly compliance certificate under SEBI regulations for the quarter ended 31st March, 2026. The pharmaceutical company filed the mandatory certificate with both BSE and NSE, demonstrating adherence to regulatory requirements for dematerialisation procedures.

Regulatory Compliance Details

The certificate was submitted under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. This regulation mandates companies to confirm proper handling of securities received for dematerialisation during each quarter.

Certificate Confirmation

MUFG Intime India Private Limited, formerly Link Intime India Private Limited, issued the confirmation certificate on April 3, 2026. The registrar confirmed that all securities received from depository participants for dematerialisation during Q4FY26 were properly processed within prescribed timelines.

The certificate specifically confirms that:

• Securities received for dematerialisation were accepted or rejected appropriately
• Security certificates were mutilated and cancelled after due verification
• Depository names were substituted in the register of members as registered owners
• All procedures were completed within regulatory timelines

Stock Exchange Filing

Company Secretary and Compliance Officer Vineet Gawankar submitted the certificate to both major stock exchanges on 8th April, 2026. The filing ensures transparency and regulatory compliance for shareholders and market participants.

This quarterly submission represents Gujarat Themis Biosyn Limited's ongoing commitment to maintaining regulatory compliance and transparent corporate governance practices in accordance with SEBI guidelines.